Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders Several Maryland Biotech Firms Are Blazing New Trails in Gene Therapy, Drugs and Diagnostics for Neurological Disorders A Maryland-based biotechnology firm seems to have solved a puzzling issue for drug targeting and delivery that may usher in an era of gene [….]
Presented by Maryland Life Sciences (MDLS), a division of the Maryland Tech Council, the Bio Innovation Conference showcases Maryland’s innovation and success in the life sciences industry. The Bio Innovation Conference will connect more than 300 top life sciences professionals in the region with leading global brands, venture capitalists and promising startups, while embracing the [….]
Why Developing Cures for Rare Disease Isn’t So Rare Anymore These Six Maryland Biotech Companies Are Seeing Success in Targeting Rare Diseases September 3, 2019 Groundbreaking technology and scientific advancements, including cell and gene therapy, have fundamentally changed the way life science companies see rare disease drug development. Life science giants like Pfizer, Merck and [….]
Five Cell and Gene Therapy Companies that Are Changing the Landscape of the Field
BioBuzz Panel on Drug Development in Rare Diseases with regional leaders from AstraZeneca, REGENXBIO, American Gene Technologies, GeneDx and Jeeva Informatics
Leaders Discuss Top Priorities for Workforce & Infrastructure to Grow BioHealth Capital Region April 3, 2019 Scientists, engineers, life science executives, academics, government officials and other constituents recently gathered to discuss the state of the BioHealth Capital Region (BHCR) at the annual Mid Atlantic Science & Technology (MAST) Showcase, hosted by the International Society for [….]
